Tag: new

Cancer Therapy Stock Advaxis Will Benefit From IPO From Rival Aduro

| March 23, 2015 | 0 Comments

NEW YORK (TheStreet) — Aduro Biotech, which is developing listeria-based immunotherapy for pancreatic cancer, filed to raise $86 million in an initial public offering.

Continue Reading

BeyondSpring Extends Plinabulin IP Portfolio With Two New Method of Treatment Patent Applications

| March 23, 2015 | 0 Comments

NEW YORK — BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced that it has filed two new method of …

Continue Reading

New miracle vaccine could be 'game-changer' in battle against cancers

| March 22, 2015 | 0 Comments

A NEW vaccine has been hailed as a “game-changer” in the fight against cancer, it was revealed today.

Continue Reading

New miracle vaccine could be 'game-changer' in battle against cancers

| March 22, 2015 | 0 Comments

A NEW vaccine has been hailed as a “game-changer” in the fight against cancer, it was revealed today.

Continue Reading

Corrected – New market for liver disease spawns race for better testing

| March 17, 2015 | 0 Comments

(Corrects name of Colorado hospital in 24th paragraph) By Bill Berkrot NEW YORK (Reuters) – As drugmakers develop new medicines to battle a liver disease epidemic, they have created an urgent need for better diagnostics to select patients for treatment and assess their drugs' effectiveness. About 30 percent of people in the U.S.

Continue Reading

Stanford Lab Explores Fundamental Nature of Cancer Using Mass Spectrometry

| March 17, 2015 | 0 Comments

NEW YORK, March 17, 2015 /PRNewswire-USNewswire/ — Stanford University Chemistry Department's Zarelab is pioneering an innovative and multidisciplinary approach to understanding more deeply the biochemical processes related to how cancer begins and progresses. By combining sophisticated…

Continue Reading

New market for liver disease spawns race for better testing

| March 15, 2015 | 0 Comments

By Bill Berkrot NEW YORK (Reuters) – As drugmakers develop new medicines to battle a liver disease epidemic, they have created an urgent need for better diagnostics to select patients for treatment and assess their drugs' effectiveness. About 30 percent of people in the U.S. now suffer from fatty liver diseases, such as NASH (nonalcoholic steatohepatitis), fueled by obesity, diabetes and over …

Continue Reading

Study: Tetanus shot may aid treatment of deadly brain cancer

| March 11, 2015 | 0 Comments

NEW YORK (AP) — Can a tetanus shot help treat brain cancer? A small study hints that it might.

Continue Reading

Study: Tetanus shot may aid treatment of deadly brain cancer – Quincy Herald-Whig | Illinois & Missouri News, Sports

| March 11, 2015 | 0 Comments

NEW YORK (AP) – Can a tetanus shot help treat brain cancer? A small study hints that it might.

Continue Reading

New Cancer Diagnostic Primed to Change the Industry

| March 5, 2015 | 0 Comments

NEW YORK, NY and VANCOUVER, BC / ACCESSWIRE / March 5, 2015 / BioMark Diagnostics (CSE: BUX; 20B.F; OTCQB: BMKDF) –The ultimate goal in the cancer diagnostics sector is to establish anassay that is capable …

Continue Reading